Format

Send to

Choose Destination
Pigment Cell Melanoma Res. 2016 Sep;29(5):590-7. doi: 10.1111/pcmr.12498. Epub 2016 Aug 3.

The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations.

Author information

1
Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
2
Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
3
Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.
4
Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.

Abstract

The remarkable success of immune therapies emphasizes the need for immune-competent cancer models. Elegant genetically engineered mouse models of a variety of cancers have been established, but their effective use is limited by cost and difficulties in rapidly generating experimental data. Some mouse cancer cell lines are transplantable to immunocompetent host mice and have been utilized extensively to study cancer immunology. Here, we describe the Yale University Mouse Melanoma (YUMM) lines, a comprehensive system of mouse melanoma cell lines that are syngeneic to C57BL/6, have well-defined human-relevant driver mutations, and are genomically stable. This will be a useful tool for the study of tumor immunology and genotype-specific cancer biology.

KEYWORDS:

YUMM; cancer immunology; cell lines; melanoma; mouse models

PMID:
27287723
PMCID:
PMC5331933
DOI:
10.1111/pcmr.12498
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center